BDBM647583 US20240025893, Example e-02-02::US20240025893, Example e-02-12

SMILES C[C@H]1CN(CCN1[C@H]1C[C@H](C1)C(=O)Nc1cc2cc(ccn2n1)-c1cnc(CO[C@H]2CCC[C@@H]2O)nc1)C(=O)c1cccnc1

InChI Key InChIKey=KIDCFCVFXFXJMJ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 647583   

TargetInterleukin-1 receptor-associated kinase 4(Human)
Asahi Kasei Pharma

US Patent
LigandPNGBDBM647583(US20240025893, Example e-02-12 | US20240025893, Ex...)
Affinity DataIC50: 1.38nMAssay Description:For the measurement of the activity of the human IRAK-4 (Invitrogen, Cat. PV3362), phosphorylation of the IRAK-4 peptide substrate (biotin-KKKKRFSFKK...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Asahi Kasei Pharma

US Patent
LigandPNGBDBM647583(US20240025893, Example e-02-12 | US20240025893, Ex...)
Affinity DataIC50: 1.90nMAssay Description:For the measurement of the activity of the human IRAK-4 (Invitrogen, Cat. PV3362), phosphorylation of the IRAK-4 peptide substrate (biotin-KKKKRFSFKK...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
US Patent